Enhanced growth suppression of TERT-positive tumor cells by oncolytic adenovirus armed with CCL20 and CD40L-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhanced growth suppression of TERT-positive tumor cells by oncolytic adenovirus armed with CCL20 and CD40L

Published:2015-09 Issue:1 Volume:28 Page:487-493
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Liu Guang-yao,Li Zhi-jie,Li Qing-lin,Jin Yan,Zhu Yu-hui,Wang Yue-hui,Liu Ming-yuan,Li Ya-gang,Li Yang

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Basic research project of Jilin University

Jilin University personnel development fund

Jilin Province Postdoctoral Science Foundation

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference27 articles.

1. Current developments in adenovirus-based cancer gene therapy;Rein;Future Oncol.,2006

2. Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls;Appaiahgari;Expert. Opin. Biol. Ther.,2014

3. Adenoviral vector-mediated gene transfer for human gene therapy;Breyer;Curr. Gene Ther.,2001

4. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells;Bischoff;Science,1996

5. Adenovirus-based vaccines for fighting infectious diseases and cancer: progress in the field;Majhen;Hum. Gene Ther.,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Double-modified oncolytic adenovirus armed with a recombinant interferon-like gene enhanced abscopal effects against malignant glioma;Neuro-Oncology Advances;2023-01-01

2. Overview of the pre-clinical and clinical studies about the use of CAR-T cell therapy of cancer combined with oncolytic viruses;World Journal of Surgical Oncology;2022-01-13

3. Oncolytic Adenoviruses for Cancer Therapy;International Journal of Molecular Sciences;2021-03-03

4. Cytokines in oncolytic virotherapy;Cytokine & Growth Factor Reviews;2020-12

5. Design and application of oncolytic viruses for cancer immunotherapy;Current Opinion in Biotechnology;2020-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3